We are live on
!
Find out more
SG Americas Securities Portfolio holdings
AUM
$92.9B
1-Year Est. Return
36.98%
This Fund
S&P 500
This Quarter
Est. Return
+9.83%
1 Year Est. Return
+36.98%
3 Year Est. Return
+96.33%
5 Year Est. Return
+110.18%
10 Year Est. Return
+482.15%
AUM
$20.8B
AUM Growth
+$10.1B
(+94%)
Cap. Flow
-$1.52B
Cap. Flow
% of AUM
-7.31%
Top 10 Holdings %
Top 10 Hldgs %
21.88%
Holding
3,605
New
545
Increased
1,142
Reduced
1,089
Closed
681
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$972M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$552M |
| 3 |
Microsoft
MSFT
|
+$538M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$269M |
| 5 |
NVIDIA
NVDA
|
+$239M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$237M |
| 2 |
SPDR Gold Trust
GLD
|
+$137M |
| 3 |
Broadcom
AVGO
|
+$110M |
| 4 |
Amgen
AMGN
|
+$96.6M |
| 5 |
Amazon
AMZN
|
+$88.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.95% |
| 2 | Financials | 10.03% |
| 3 | Healthcare | 8.9% |
| 4 | Industrials | 7.78% |
| 5 | Consumer Discretionary | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Latham Group
SWIM
$857M
| $54K | ﹤0.01% |
13,580
-13,428
| -50% | -$38.3K |
|
|
NAGE
2677
Niagen Bioscience
NAGE
$234M
| $54K | ﹤0.01% |
+15,423
| New | +$28.5K |
|
2678
LiveOne
LVO
$57.2M
| $53K | ﹤0.01% |
+2,707
| New | +$43K |
|
2679
NN Inc
NNBR
$301M
| $53K | ﹤0.01% |
+11,080
| New | +$50.9K |
|
2680
PUT
Philip Morris
PM
$294B
| $53K | ﹤0.01% |
31,700
| – | – |
|
2681
Relmada Therapeutics
RLMD
$574M
| $53K | ﹤0.01% |
+11,320
| New | +$54.5K |
|
2682
Acumen Pharmaceuticals
ABOS
$162M
| $52K | ﹤0.01% |
+12,856
| New | +$48.5K |
|
2683
PUT
Analog Devices
ADI
$184B
| $52K | ﹤0.01% |
22,600
-58,500
| -72% | -$11.2M |
|
2684
PUT
Aflac
AFL
$63.7B
| $52K | ﹤0.01% |
+38,300
| New | +$3.14M |
|
2685
AXT Inc
AXTI
$4.49B
| $52K | ﹤0.01% |
+11,256
| New | +$38.2K |
|
2686
PUT
Cencora
COR
$61.7B
| $52K | ﹤0.01% |
+15,000
| New | +$3.45M |
|
2687
PUT
Corteva
CTVA
$52.5B
| $52K | ﹤0.01% |
+37,000
| New | +$1.91M |
|
2688
PUT
Honeywell
HON
$78.6B
| $52K | ﹤0.01% |
77,347
| – | – |
|
2689
CALL
Kraft Heinz
KHC
$30.5B
| $52K | ﹤0.01% |
67,500
| – | – |
|
2690
Kopin
KOPN
$732M
| $52K | ﹤0.01% |
+29,000
| New | +$64.4K |
|
2691
Arbutus Biopharma
ABUS
$913M
| $51K | ﹤0.01% |
19,644
-26,528
| -57% | -$68.7K |
|
|
NXDR
2692
Nextdoor Holdings
NXDR
$948M
| $51K | ﹤0.01% |
22,592
-764,679
| -97% | -$1.43M |
|
|
EXK
2693
Endeavour Silver
EXK
$2.65B
| $50K | ﹤0.01% |
20,603
+7,852
| +62% | +$14K |
|
2694
Pixelworks
PXLW
$40.6M
| $50K | ﹤0.01% |
+1,628
| New | +$43.2K |
|
2695
Trevi Therapeutics
TRVI
$2.66B
| $50K | ﹤0.01% |
14,592
-83,661
| -85% | -$187K |
|
|
LICY
2696
DELISTED
Li-Cycle Holdings Corp.
LICY
| $50K | ﹤0.01% |
6,023
-10,718
| -64% | -$48.2K |
|
|
CLSD
2697
DELISTED
Clearside Biomedical
CLSD
| $49K | ﹤0.01% |
+2,151
| New | +$46.4K |
|
|
FRGE
2698
DELISTED
Forge Global Holdings
FRGE
| $49K | ﹤0.01% |
1,694
-1,760
| -51% | -$55K |
|
2699
HF Foods Group
HFFG
$78.1M
| $49K | ﹤0.01% |
14,006
-8,025
| -36% | -$35.1K |
|
2700
TETRA Technologies
TTI
$1.25B
| $48K | ﹤0.01% |
10,894
-23,590
| -68% | -$98K |
|
Similar funds
SG Americas Securities's Q1 2024 Portfolio in Review
As of Q1 2024, SG Americas Securities held 3,605 positions worth $20.8B, up 94% from $10.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
SG Americas Securities withdrew a net $1.52B in Q1 2024, closing 681 positions and reducing 1,089 holdings. Its most notable exit was Karuna Therapeutics, Inc. Common Stock, an estimated $55.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, SG Americas Securities opened a new position in iShares ESG Aware MSCI USA ETF worth $47.8M.
- SG Americas Securities's largest Q1 2024 buy was iShares ESG Aware MSCI USA ETF: 415,857 shares worth $47.8M.
- SG Americas Securities added most to Apple in Q1 2024, an estimated $972M increase.
- SG Americas Securities's biggest Q1 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $237M.
- SG Americas Securities fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $55.1M.
- SG Americas Securities's ten largest holdings make up 22% of its $20.8B portfolio in Q1 2024.
- SG Americas Securities opened 545 new positions and closed 681 in Q1 2024.
- SG Americas Securities's portfolio value rose 94% quarter-over-quarter to $20.8B.
Based on SG Americas Securities's 13F filing for Q1 2024, filed 6 May 2024.